Biologics Outsourcing Market to Touch USD 70.3 Bn by 2025, Predicts IQ4I Research in Its New Topical Report Available at MarketPublishers.com
11 Sep 2017 • by Natalie Aster
LONDON – Though biologics are more expensive than small molecule drugs, these classes of drugs prove to be highly beneficial for patients and also bring around 40% higher profit to manufacturers in comparison to small molecule drug treatments. Owing to the escalating demand for biologics drugs and enhancing regulatory approvals for these classes of drugs, there is strong demand for biologics manufacture and testing at different levels of clinical studies and also commercial supply.
The large PharmaCos engaged in the biologics field are implementing various strategies to cut down on their operational costs and also makes a greater focus on their core competencies by outsourcing this part of work to CROs, CMOs and CDMOs. These organisations bridge the gap between supply and demand and ensure the drug discovery process gets much convenient and faster thus bringing life saving drugs to the market to reach the needy patients.
In the past year, 8 of 10 blockbuster drugs were biologics demonstrating s steep growth in adoption of biologics in comparison to small molecule drugs. The top selling biologics included Humira, Rituxan, Hereptin, Prevnar.
The world’s market for biologics outsourcing is projected to increase at a double-digit CAGR in the years ahead to touch the value of USD 70.3 billion by the year 2025.
New topical study “Biologics Outsourcing Global Market - Forecast to 2025” drawn up by IQ4I Research & Consultancy gives in-depth insights into the global market for biologics outsourcing, providing a detailed market landscape analysis, examining the market dynamics and identifying the key market growth driving forces, lucrative opportunities and major challenges. Besides, the report describes the competitive environment, offers valuable info on the leading companies, discusses the prevailing and emerging trends, as well as presents access to future forecasts through 2025.
For other topical research studies by this publisher follow IQ4I Research & Consultancy page at MarketPublishers.com.